Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.
暂无分享，去创建一个
K. Syrigos | V. Georgoulias | A. Alegakis | N. Samaras | A. Polyzos | A. Ardavanis | V. Chandrinos | P. Papakotoulas | C. Kouroussis | M. Toumbis | N. Ziras | E. Tsaroucha | M. Agelidou | A. Agelidou | C. Christofilakis